Skip to main content

IMAX Corporation Reports Q2 Results

  • Growth in network sales and installations and box office combine to deliver strong financial results for global entertainment technology platform, including over 25% YoY increase in Net Income, Adjusted EBITDA(1), EPS and Adjusted EPS(1)
  • Increasing demand for IMAX drives network growth momentum with 36 system installations in Q2 (+50% YoY) and 123 signings year-to-date (vs. 130 in full year 2024)
  • Strong YoY growth in IMAX box office (+41%) contributes to high incremental profits with Net Income margin of 13%, up 760 basis points YoY and Adjusted EBITDA(1) margin of 43%, up 780 basis points YoY
  • IMAX share of global box office surges +19% YoY in Q2 as Company delivers highest grossing quarter ever at the North American box office ($143 million)

IMAX Corporation (NYSE: IMAX) today reported strong financial results for the second quarter of 2025, demonstrating the value of its unique global entertainment platform and broad content portfolio.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250724890729/en/

Infographic highlighting IMAX's 2Q 2025 earnings results.

Infographic highlighting IMAX's 2Q 2025 earnings results.

“IMAX delivered outstanding financial results in the Second Quarter as the key drivers of our business worked in concert, with strong network growth worldwide, record box office in North America, and impressive market share gains driven by more releases filmed with our technology than ever,” said Rich Gelfond, CEO of IMAX.

“Our results are driven in part by strong network growth, with 57 IMAX locations opened worldwide and system sales pacing well ahead of 2024 through the first six months of the year. The strength of our system installations this early in the year is a strong indicator of our momentum, as our exhibition partners worldwide are clearly looking to capitalize on our surging share of the global box office.”

“With the Third Quarter off to a very strong start, IMAX is taking its performance to the next level year to date. We remain on track to deliver a record $1.2 billion in global box office in 2025. Our market share on this summer slate has reached all-time highs thanks to an unprecedented run of eight Filmed for IMAX® releases shot with our cameras, for our screens. And we are pacing well ahead of our projections for IMAX system sales and installations around the world.”

“The fundamentals of our business are strong, the strength and impact of our brand across the entertainment landscape has reached new highs, and we have tremendous runway with a strong slate and network growth prospects ahead.”

_______________
(1)

Non-GAAP Financial Measure. See the discussion at the end of this earnings release for a description of the non-GAAP financial measures used herein, as well as reconciliations to the most comparable GAAP amounts.

Second Quarter Financial Highlights

 

 

Three Months Ended June 30,

(Unaudited)

 

Six Months Ended June 30,

(Unaudited)

In millions of U.S. Dollars, except per share data

2025

 

2024

 

YoY %

Change

 

2025

 

2024

 

YoY %

Change

Total Revenue

$

91.7

 

 

$

89.0

 

 

3

%

 

$

178.4

 

 

$

168.1

 

 

6

%

 

 

 

 

 

 

 

 

 

 

 

 

Gross Margin

$

53.6

 

 

$

43.9

 

 

22

%

 

$

106.8

 

 

$

90.8

 

 

18

%

Gross Margin (%)

 

58.5

%

 

 

49.4

%

 

9.1bps

 

 

59.9

%

 

 

54.0

%

 

5.9bps

 

 

 

 

 

 

 

 

 

 

 

 

Net Income

$

12.2

 

 

$

5.1

 

 

139

%

 

$

20.4

 

 

$

10.5

 

 

94

%

Net Income Margin (%)

 

13.3

%

 

 

5.7

%

 

7.6bps

 

 

11.4

%

 

 

6.2

%

 

5.2bps

 

 

 

 

 

 

 

 

 

 

 

 

Net Income Attributable to Common Shareholders

$

11.3

 

 

$

3.6

 

 

214

%

 

$

13.6

 

 

$

6.9

 

 

97

%

Diluted Net Income Per Share(1)

$

0.20

 

 

$

0.07

 

 

186

%

 

$

0.25

 

 

$

0.13

 

 

92

%

 

 

 

 

 

 

 

 

 

 

 

 

Total Adjusted EBITDA(2)(3)

$

39.1

 

 

$

31.0

 

 

26

%

 

$

76.0

 

 

$

63.1

 

 

20

%

Total Adjusted EBITDA Margin (%)(2)(3)

 

42.6

%

 

 

34.8

%

 

7.8bps

 

 

42.6

%

 

 

37.5

%

 

5.1bps

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted Net Income(1)(2)

$

14.6

 

 

$

9.7

 

 

51

%

 

$

21.8

 

 

$

17.7

 

 

23

%

Adjusted Earnings Per Share - Diluted(1)(2)

$

0.26

 

 

$

0.18

 

 

44

%

 

$

0.40

 

 

$

0.33

 

 

21

%

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding (in millions):

 

 

 

 

 

 

 

 

 

 

 

Basic

 

53.8

 

 

 

52.6

 

 

2

%

 

 

53.4

 

 

 

52.6

 

 

2

%

Diluted

 

55.2

 

 

 

53.4

 

 

3

%

 

 

55.1

 

 

 

53.4

 

 

3

%

_______________
(1)

Attributable to common shareholders.

(2)

Non-GAAP Financial Measure. See the discussion at the end of this earnings release for a description of the non-GAAP financial measures used herein, as well as reconciliations to the most comparable GAAP amounts.

(3)

Total Adjusted EBITDA is before adjustments for non-controlling interests. Total Adjusted EBITDA per Credit Facility attributable to common shareholders, excluding non-controlling interests, was $36.7 million and $65.7 million for the three and six months ended June 30, 2025, respectively (2024 - $26.9 million and $55.0 million, respectively). The Company’s Credit Facility covenant is calculated on a trailing twelve-month basis.

 
Second Quarter Segment Results(1)
 

 

Content Solutions

 

Technology Products and Services

 

Revenue

 

Gross Margin

 

Gross

Margin %

 

Revenue

 

Gross Margin

 

Gross

Margin %

2Q25

$

34.0

 

 

$

22.4

 

 

66

%

 

$

55.6

 

 

$

30.2

 

 

54

%

2Q24

 

35.1

 

 

 

16.1

 

 

46

%

 

 

50.9

 

 

 

25.8

 

 

51

%

% change

 

(3

%)

 

 

39

%

 

 

 

 

9

%

 

 

17

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

YTD25

$

68.2

 

 

$

46.0

 

 

67

%

 

$

106.2

 

 

$

59.3

 

 

56

%

YTD24

 

69.1

 

 

 

38.2

 

 

55

%

 

 

94.0

 

 

 

49.4

 

 

52

%

% change

 

(1

%)

 

 

20

%

 

 

 

 

13

%

 

 

20

%

 

 

_______________

(1) Please refer to the Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2025 for additional segment information.

Content Solutions Segment

  • Content Solutions revenue of $34.0 million decreased 3% year-over-year. Second quarter 2025 IMAX gross box office increased 41% year-over-year to $281.1 million, which was offset by the sale of streaming rights for “The Blue Angels” documentary in the prior year comparative period.
  • Box office growth was driven by a record number of Filmed for IMAX releases including three titles (“Sinners,” “Mission: Impossible - The Final Reckoning” and “F1 The Movie”) where IMAX delivered approximately 20% or more of the opening weekend domestic box office contributing to a growth of 19% in global box office market share to 3.6% (on less than 1% of screens).
  • Gross margin for Content Solutions of $22.4 million increased 39% year-over-year. The Company saw significant Content Solutions margin expansion going from 46% in Q2 2024 to 66% in Q2 2025, driven by the operating leverage in our business that accompanies box office growth along with the mix of revenues toward higher margin streams.

Technology Products and Services Segment

  • Technology Products and Services revenues and gross margin increased 9% year-over-year to $55.6 million and 17% year-over-year to $30.2 million, respectively.
  • Demand for IMAX systems is growing, during the second quarter of 2025, the Company installed 36 systems, up 50% compared to 24 systems in the second quarter of 2024. Of the 2025 installations, 13 systems were under sales arrangements, compared to 10 in the prior year.
  • Commercial network growth continues with the number of IMAX locations increasing to 1,750 from 1,705 in the prior year period. The Company ended the second quarter with a backlog of 501 IMAX systems.

Operating Cash Flow and Liquidity

Net cash provided by operating activities for first half 2025 increased 25% year-over-year to $30 million, reflecting improvements in working capital driven by higher collections.

On July 14, 2025, the Company renewed and expanded its senior secured revolving credit facility, increasing the Company's borrowing capacity from $300 million to $375 million. The renewed facility includes a reduction in borrowing costs, reflecting improved market conditions and the Company's strong financial position. The facility is designed to provide IMAX with increased financial flexibility to support ongoing operational needs, network expansion, the refinancing of existing debt and other general corporate purposes.

As of June 30, 2025, the Company’s available liquidity was $416 million (with the expanded credit facility referenced above the Company’s liquidity is approximately $490 million as of the date of this press release). The Company’s liquidity included cash and cash equivalents of $109 million, $252 million in available borrowing capacity under the Company’s credit facility, and $54 million in available borrowing capacity under IMAX China’s revolving facilities. Total debt, excluding deferred financing costs, was $280 million as of June 30, 2025.

In 2021, the Company issued $230 million of 0.500% Convertible Senior Notes due 2026 (“Convertible Notes”). In connection with the pricing of the Convertible Notes, the Company entered into privately negotiated capped call transactions with an initial cap price of $37.2750 per share of the Company’s common shares.

Share Count and Capital Return

The weighted average basic and diluted shares outstanding in the second quarter of 2025 were 53.8 million and 55.2 million, respectively, compared to 52.6 million and 53.4 million in the second quarter of 2024.

For the first half of 2025, IMAX China repurchased 1,495,900 common shares at an average price of HKD 7.56 per share ($0.96 per share) for a total of HKD 11.3 million ($1 million), excluding commissions.

In June 2025, the Company’s Board of Directors approved an extension of its share repurchase program through June 30, 2027 and an increase of approximately $100 million in the Company’s share repurchase program. As of June 30, 2025, The Company’s total share repurchase authority is $500 million with approximately $251 million available under the program.

Supplemental Materials

For more information about the Company’s results, please refer to the IMAX Investor Relations website located at investors.imax.com.

Investor Relations Website and Social Media

On a monthly basis, the Company posts quarter-to-date box office results on the IMAX Investor Relations website located at investors.imax.com. The Company expects to provide such updates within five business days of month-end, although the Company may change this timing without notice.

The Company may post additional information on the Company’s corporate and Investor Relations websites which may be material to investors. Accordingly, investors, media and others interested in the Company should monitor the Company’s website in addition to the Company’s press releases, United States Securities and Exchange Commission (the “SEC”) or in Canada, the System for Electronic Data Analysis and Retrieval (“SEDAR+”); filings and public conference calls and webcasts, for additional information about the Company. References to our website address and domain names throughout this release are for informational purposes only, or to fulfill specific disclosure requirements of the SEC’s rules or The New York Stock Exchange Listing Standards. These references are not intended to, and do not, incorporate the contents of our websites by reference into this release.

Conference Call

The Company will host a conference call today at 8:30 AM ET to discuss its second quarter 2025 financial results. This call is being webcast and can be accessed at investors.imax.com. To access the call via telephone, interested parties please pre-register at: https://register-conf.media-server.com/register/BI78025cca567349fd9d1791a59fb53ec9 and you will be provided with a dial-in number and unique pin. To avoid delays, we encourage participants to dial into the conference call ten minutes ahead of the scheduled start time. A replay of the call will be available via webcast at investors.imax.com.

About IMAX Corporation

IMAX, an innovator in entertainment technology, combines proprietary software, architecture, and equipment to create experiences that take you beyond the edge of your seat to a world you’ve never imagined. Top filmmakers and studios are utilizing IMAX systems to connect with audiences in extraordinary ways, making IMAX’s network among the most important and successful theatrical distribution platforms for major event films around the globe.

IMAX is headquartered in New York, Toronto, and Los Angeles, with additional offices in London, Dublin, Tokyo, and Shanghai. As of June 30, 2025, there were 1,821 IMAX systems (1,750 commercial multiplexes, 11 commercial destinations, 60 institutional) operating in 89 countries and territories. Shares of IMAX China Holding, Inc., a subsidiary of IMAX Corporation, trade on the Hong Kong Stock Exchange under the stock code “1970”.

IMAX®, IMAX 3D®, Experience It In IMAX®, The IMAX Experience®, DMR®, Filmed For IMAX®, IMAX Live®, IMAX Enhanced® and IMAX StreamSmart™ are trademarks and trade names of the Company or its subsidiaries that are registered or otherwise protected under laws of various jurisdictions. For more information, visit www.imax.com. You can also connect with IMAX on Instagram (www.instagram.com/imax), Facebook (www.facebook.com/imax), LinkedIn (www.linkedin.com/company/imax), X (www.twitter.com/imax), and YouTube (www.youtube.com/imaxmovies).

Forward-Looking Statements

This earnings release contains forward looking statements that are based on IMAX Corporation (the “Company”) management’s assumptions and existing information and involve certain risks and uncertainties which could cause actual results to differ materially from future results expressed or implied by such forward looking statements. In some cases, you can identify these statements by forward-looking words such as “believe,” “continue,” “expect,” “may,” “project,” “momentum,” “on track,” “prospects,” “runway,” “will” or the negative or other variations thereon or comparable terminology. These forward-looking statements include, but are not limited to, statements regarding business and technology strategies and measures to implement strategies, statements about the Company’s belief and expectations, competitive strengths, goals, market opportunity and penetration, including opportunities in and expected growth from international markets, momentum and runway for expansion and growth of business, network, operations and technology, future capital expenditures (including the amount and nature thereof), the Company’s technological capabilities and the differentiation thereof, brand equity and brand awareness and the benefits thereof, industry prospects and consumer behavior, future industry developments, including expected releases and the timing and effects thereof, plans and references to the future success of the Company and expectations regarding its future operating, financial and technological results, including its box office guidance for 2025. These forward-looking statements are based on certain assumptions and analyses made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments, as well as other factors it believes are appropriate in the circumstances. However, whether actual results and developments will conform with the expectations and predictions of the Company is subject to a number of risks and uncertainties, including, but not limited to, risks associated with investments and operations in foreign jurisdictions and any future international expansion, including those related to economic, political and regulatory policies of local governments and laws and policies of the United States, Canada, and China, including with respect to escalating and uncertain tariffs and other trade regulations, as well as economic and trade tensions, trade wars, and geopolitical conflicts and the effects thereof; risks related to the Company’s growth and operations in China; industry conditions in China affecting both the Company and its partners; risks related to the failure of the Company’s exhibitors being able to fulfill their contractual payment obligations; risks related to the Company’s failure to attract and retain its employee population; the performance of IMAX remastered films and other films released to the IMAX network; the signing of IMAX System agreements; conditions, changes and developments in the commercial exhibition industry; risks related to the Company’s inability to enter into new sales and lease agreements adversely affecting revenue; risks related to the Company’s operating results and cash flow increasing the volatility of the Company’s share price; risks related to currency fluctuations and foreign exchange controls; the potential impact of increased competition in the markets within which the Company operates, including competitive actions by other companies; the failure to respond to change and advancements in technology; risks relating to consolidation among commercial exhibitors and studios; risks related to brand extensions and new business initiatives; conditions in the in-home and out-of-home entertainment industries; the opportunities (or lack thereof) that may be presented to and pursued by the Company; risks related to cybersecurity and data privacy; risks related to the Company’s inability to protect its intellectual property and to avoid infringing, misappropriating, or violating the intellectual property rights of others; risks associated with the Company’s use of artificial intelligence (“AI”) and exploration of additional use cases of AI; risks related to climate change; risks related to weather conditions and natural disasters that may disrupt or harm the Company’s business; risks related to the Company’s indebtedness and compliance with its debt agreements; general economic, market or business conditions; risks related to sustained inflationary pressure; risks related to political, economic and social instability; the failure to convert system backlog into revenue and cash flows; changes in laws or regulations; any statements of belief and any statements of assumptions underlying any of the foregoing; other factors and risks outlined in the Company’s periodic filings with the United States Securities and Exchange Commission (the “SEC”) or in Canada, the System for Electronic Data Analysis and Retrieval (“SEDAR+”); and other factors, many of which are beyond the control of the Company. Consequently, all of the forward-looking statements made in this earnings release are qualified by these cautionary statements, and actual results or anticipated developments by the Company may not be realized, and even if substantially realized, may not have the expected consequences to, or effects on, the Company. These factors, other risks and uncertainties and financial details are discussed in the Company’s most recent Annual Report on Form 10-K, as supplemented by those discussed in the Company’s Quarterly Report on Form 10-Q. The Company undertakes no obligation to update publicly or otherwise revise any forward-looking statements, whether as a result of new information, future events or otherwise.

IMAX Network and Backlog

 

 

Three Months Ended

 

Six Months Ended

 

June 30,

 

June 30,

 

2025

 

2024

 

2025

 

2024

System Signings(1):

 

 

 

 

 

 

 

Sales Arrangements

15

 

25

 

34

 

30

Traditional JRSA

13

 

62

 

89

 

65

Total IMAX System Signings

28

 

87

 

123

 

95

 

 

 

 

 

 

 

 

(1) System signings include new signings of 26 in Q2 2025, 63 in YTD 2025, 19 in Q2 2024 and 27 YTD 2024.

 

Three Months Ended

 

Six Months Ended

 

June 30,

 

June 30,

 

2025

 

2024

 

2025

 

2024

System Installations(1):

 

 

 

 

 

 

 

Sales Arrangements

13

 

10

 

26

 

15

Hybrid JRSA

 

 

 

1

Traditional JRSA

23

 

14

 

31

 

23

Total IMAX System Installations

36

 

24

 

57

 

39

 

 

 

 

 

 

 

 

(1) System installations include new systems installations of 18 in Q2 2025, 32 in Q2 YTD, 13 in Q2 2024, and 28 in YTD 2024.

 

As of June 30,

 

2025

 

2024

System Backlog:

 

 

 

Sales Arrangements

165

 

177

Hybrid JRSA

94

 

101

Traditional JRSA

242

 

226

Total System Backlog

501

 

504

 

 

 

 

 

As of June 30,

 

2025

 

2024

System Network:

 

 

 

Commercial Multiplex Systems

 

 

 

Sales Arrangements

851

 

807

Hybrid JRSA

119

 

138

Traditional JRSA

780

 

760

Total Commercial Multiplex Systems

1,750

 

1,705

Commercial Destination Systems

11

 

12

Institutional Systems

60

 

63

Total System Network

1,821

 

1,780

IMAX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands of U.S. dollars, except per share amounts)

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

(Unaudited)

 

(Unaudited)

 

2025

 

2024

 

2025

 

2024

Revenues

 

 

 

 

 

 

 

Technology sales

$

18,842

 

 

$

20,420

 

 

$

32,366

 

 

$

28,324

 

Image enhancement and maintenance services

 

50,854

 

 

 

52,189

 

 

 

101,607

 

 

 

102,537

 

Technology rentals

 

19,116

 

 

 

14,043

 

 

 

38,427

 

 

 

32,644

 

Finance income

 

2,872

 

 

 

2,309

 

 

 

5,951

 

 

 

4,579

 

 

 

91,684

 

 

 

88,961

 

 

 

178,351

 

 

 

168,084

 

Costs and expenses applicable to revenues

 

 

 

 

 

 

 

Technology sales

 

9,352

 

 

 

9,222

 

 

 

16,575

 

 

 

13,989

 

Image enhancement and maintenance services

 

21,376

 

 

 

29,089

 

 

 

40,821

 

 

 

50,284

 

Technology rentals

 

7,354

 

 

 

6,723

 

 

 

14,177

 

 

 

12,995

 

 

 

38,082

 

 

 

45,034

 

 

 

71,573

 

 

 

77,268

 

Gross margin

 

53,602

 

 

 

43,927

 

 

 

106,778

 

 

 

90,816

 

Selling, general and administrative expenses

 

35,302

 

 

 

37,564

 

 

 

68,764

 

 

 

68,821

 

Research and development

 

1,542

 

 

 

2,031

 

 

 

2,860

 

 

 

4,218

 

Amortization of intangible assets

 

1,809

 

 

 

1,321

 

 

 

3,540

 

 

 

2,664

 

Credit loss (reversal) expense, net

 

(183

)

 

 

139

 

 

 

(309

)

 

 

174

 

Restructuring and other charges

 

786

 

 

 

 

 

 

843

 

 

 

 

Income from operations

 

14,346

 

 

 

2,872

 

 

 

31,080

 

 

 

14,939

 

Realized and unrealized investment gains

 

33

 

 

 

32

 

 

 

65

 

 

 

62

 

Retirement benefits non-service expense

 

(133

)

 

 

(107

)

 

 

(203

)

 

 

(214

)

Interest income

 

1,114

 

 

 

561

 

 

 

1,654

 

 

 

1,095

 

Interest expense

 

(1,927

)

 

 

(2,282

)

 

 

(3,728

)

 

 

(4,227

)

Income before taxes

 

13,433

 

 

 

1,076

 

 

 

28,868

 

 

 

11,655

 

Income tax (expense) benefit

 

(1,198

)

 

 

3,997

 

 

 

(8,483

)

 

 

(1,162

)

Net income

 

12,235

 

 

 

5,073

 

 

 

20,385

 

 

 

10,493

 

Net income attributable to non-controlling interests

 

(980

)

 

 

(1,490

)

 

 

(6,803

)

 

 

(3,636

)

Net income attributable to common shareholders

$

11,255

 

 

$

3,583

 

 

$

13,582

 

 

$

6,857

 

 

 

 

 

 

 

 

 

Net income per share attributable to common shareholders:

 

 

 

 

 

 

 

Basic

$

0.21

 

 

$

0.07

 

 

$

0.25

 

 

$

0.13

 

Diluted

$

0.20

 

 

$

0.07

 

 

$

0.25

 

 

$

0.13

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding (in thousands):

 

 

 

 

 

 

 

Basic

 

53,751

 

 

 

52,633

 

 

 

53,448

 

 

 

52,568

 

Diluted

 

55,161

 

 

 

53,428

 

 

 

55,064

 

 

 

53,386

 

 

 

 

 

 

 

 

 

Additional Disclosure:

 

 

 

 

 

 

 

Depreciation and amortization

$

15,896

 

 

$

18,838

 

 

$

30,809

 

 

$

34,002

 

Amortization of deferred financing costs

$

492

 

 

$

493

 

 

$

984

 

 

$

985

 

IMAX CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands of U.S. dollars, except share amounts)

 

 

June 30,

 

December 31,

 

2025

 

2024

Assets

 

 

 

Cash and cash equivalents

$

109,251

 

 

$

100,592

 

Accounts receivable, net of allowance for credit losses

 

126,949

 

 

 

107,669

 

Financing receivables, net of allowance for credit losses

 

121,122

 

 

 

119,885

 

Variable consideration receivables, net of allowance for credit losses

 

83,276

 

 

 

82,593

 

Inventories

 

36,699

 

 

 

32,840

 

Prepaid expenses

 

13,171

 

 

 

13,121

 

Film assets, net of accumulated amortization

 

10,309

 

 

 

8,686

 

Property, plant and equipment, net of accumulated depreciation

 

243,672

 

 

 

240,133

 

Other assets

 

23,356

 

 

 

22,441

 

Deferred income tax assets, net of valuation allowance

 

13,630

 

 

 

14,499

 

Goodwill

 

52,815

 

 

 

52,815

 

Other intangible assets, net of accumulated amortization

 

34,332

 

 

 

35,124

 

Total assets

$

868,582

 

 

$

830,398

 

Liabilities

 

 

 

Accounts payable

$

31,721

 

 

$

19,803

 

Accrued and other liabilities

 

85,322

 

 

 

100,916

 

Deferred revenue

 

55,924

 

 

 

52,686

 

Revolving credit facility borrowings, net of unamortized debt issuance costs

 

47,547

 

 

 

36,356

 

Convertible notes and other borrowings, net of unamortized discounts and debt issuance costs

 

230,474

 

 

 

229,901

 

Deferred income tax liabilities

 

12,521

 

 

 

12,521

 

Total liabilities

 

463,509

 

 

 

452,183

 

Commitments, contingencies and guarantees

 

 

 

Non-controlling interests

 

691

 

 

 

680

 

Shareholders’ equity

 

 

 

Capital stock common shares — no par value. Authorized — unlimited number.

 

 

53,782,520 issued and outstanding (December 31, 2024 — 52,946,200 issued and outstanding)

 

415,142

 

401,420

 

Other equity

 

175,901

 

 

 

185,268

 

Statutory surplus reserve

 

4,219

 

 

 

4,051

 

Accumulated deficit

 

(261,261

)

 

 

(274,675

)

Accumulated other comprehensive loss

 

(13,589

)

 

 

(16,598

)

Total shareholders’ equity attributable to common shareholders

 

320,412

 

 

 

299,466

 

Non-controlling interests

 

83,970

 

 

 

78,069

 

Total shareholders’ equity

 

404,382

 

 

 

377,535

 

Total liabilities and shareholders’ equity

$

868,582

 

 

$

830,398

 

IMAX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands of U.S. dollars)

 

 

Six Months Ended June 30,

 

(Unaudited)

 

2025

 

2024

Operating Activities

 

 

 

Net income

$

20,385

 

 

$

10,493

 

Adjustments to reconcile net income to cash provided by operating activities:

 

 

 

Depreciation and amortization

 

30,809

 

 

 

34,002

 

Amortization of deferred financing costs

 

984

 

 

 

985

 

Credit loss (reversal) expense, net

 

(309

)

 

 

174

 

Write-downs, including asset impairments

 

1,047

 

 

 

2,399

 

Deferred income tax expense

 

72

 

 

 

(7,722

)

Share-based and other non-cash compensation

 

12,767

 

 

 

11,753

 

Unrealized foreign currency exchange (gain) loss

 

(278

)

 

 

51

 

Realized and unrealized investment gain

 

(65

)

 

 

(62

)

Changes in assets and liabilities:

 

 

 

Accounts receivable

 

(18,702

)

 

 

14,492

 

Inventories

 

(4,027

)

 

 

(6,271

)

Film assets

 

(11,318

)

 

 

(12,741

)

Deferred revenue

 

3,116

 

 

 

(4,397

)

Changes in other operating assets and liabilities

 

(4,300

)

 

 

(19,086

)

Net cash provided by operating activities

 

30,181

 

 

 

24,070

 

Investing Activities

 

 

 

Purchase of property, plant and equipment

 

(4,006

)

 

 

(2,690

)

Investment in equipment for joint revenue sharing arrangements

 

(14,666

)

 

 

(9,757

)

Acquisition of other intangible assets

 

(3,376

)

 

 

(3,191

)

Net cash used in investing activities

 

(22,048

)

 

 

(15,638

)

Financing Activities

 

 

 

Proceeds from revolving credit facility borrowings

 

29,000

 

 

 

51,000

 

Repayments of revolving credit facility borrowings

 

(18,000

)

 

 

(21,000

)

Repayments of other borrowings

 

(372

)

 

 

(311

)

Repurchase of common shares - IMAX Corporation

 

 

 

 

(18,102

)

Repurchase of common shares - IMAX China

 

(1,454

)

 

 

 

Taxes withheld and paid on employee stock awards vested

 

(9,742

)

 

 

(4,978

)

Common shares issued - stock options exercised

 

1,048

 

 

 

 

Net cash provided by financing activities

 

480

 

 

 

6,609

 

Effects of exchange rate changes on cash

 

46

 

 

 

311

 

Increase in cash and cash equivalents during period

 

8,659

 

 

 

15,352

 

Cash and cash equivalents, beginning of period

 

100,592

 

 

 

76,200

 

Cash and cash equivalents, end of period

$

109,251

 

 

$

91,552

 

Primary Reporting Groups

The Company’s Chief Executive Officer (“CEO”) is its Chief Operating Decision Maker (“CODM”), as such term is defined under U.S. GAAP. The CODM assesses segment performance based on segment revenues and segment gross margins. Selling, general and administrative expenses, research and development costs, the amortization of intangible assets, provision for (reversal of) current expected credit losses, certain write-downs, interest income, interest expense, and income tax (expense) benefit are not allocated to the Company’s segments.

The Company has two reportable segments:

  1. Content Solutions, consists of services provided to studios and other content creators, which principally includes the digital remastering of films and other content into IMAX formats for distribution to the IMAX network. To a lesser extent, the Content Solutions segment also earns revenue from the distribution of large-format documentary films and exclusive experiences ranging from live performances to interactive events with leading artists and creators, as well as film post-production services.
  2. Technology Products and Services, which includes results from the sale or lease of IMAX Systems, as well as from the maintenance of IMAX Systems to exhibition customers. To a lesser extent, the Technology Product and Services segment also earns revenue from certain ancillary theater business activities, including after-market sales of IMAX System parts and 3D glasses.

Segment Revenue and Gross Margin

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

(Unaudited)

 

(Unaudited)

(In thousands of U.S. dollars)

2025

 

2024

 

2025

 

2024

Revenue

 

 

 

 

 

 

 

Content Solutions

$

33,965

 

$

35,076

 

$

68,214

 

$

69,089

Technology Products and Services

 

55,639

 

 

50,898

 

 

106,232

 

 

94,048

Sub-total for reportable segments

 

89,604

 

 

85,974

 

 

174,446

 

 

163,137

All Other(1)

 

2,080

 

 

2,987

 

 

3,905

 

 

4,947

Total

$

91,684

 

$

88,961

 

$

178,351

 

$

168,084

 

 

 

 

 

 

 

 

Gross Margin

 

 

 

 

 

 

 

Content Solutions

$

22,431

 

$

16,138

 

$

45,985

 

$

38,237

Technology Products and Services

 

30,178

 

 

25,783

 

 

59,264

 

 

49,367

Sub-total for reportable segments

 

52,609

 

 

41,921

 

 

105,249

 

 

87,604

All Other(1)

 

993

 

 

2,006

 

 

1,529

 

 

3,212

Total

$

53,602

 

$

43,927

 

$

106,778

 

$

90,816

_______________

(1) All Other includes the results from the Company’s streaming and consumer technology business, as well as other ancillary activities.

 

IMAX CORPORATION

NON-GAAP FINANCIAL MEASURES

In this release, the Company presents adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per basic and diluted share, EBITDA, Adjusted EBITDA per Credit Facility, and Adjusted EBITDA margin as supplemental measures of the Company’s performance, which are not recognized under U.S. GAAP.

A reconciliation from net income (loss) attributable to common shareholders and the associated per share amounts to adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share is presented in the table below. Net income (loss) attributable to common shareholders and the associated per share amounts are the most directly comparable U.S. GAAP measures because they reflect the earnings relevant to the Company’s shareholders, rather than the earnings attributable to non-controlling interests.

Adjusted net income or loss attributable to common shareholders and adjusted net income or loss attributable to common shareholders per basic and diluted share exclude, where applicable: (i) share-based compensation; (ii) realized and unrealized investment gains or losses; (iii) restructuring and other charges; and (iv) employee retention credits, and as well as the related tax impact of these adjustments.

The Company believes that these non-GAAP financial measures are important supplemental measures that allow management and users of the Company’s financial statements to view operating trends and analyze controllable operating performance on a comparable basis between periods without the after-tax impact of share-based compensation and certain unusual items included in net income attributable to common shareholders. Although share-based compensation is an important aspect of the Company’s employee and executive compensation packages, it is a non-cash expense and is excluded from certain internal business performance measures.

In addition to the non-GAAP financial measures discussed above, management also uses “EBITDA,” as such term is defined in the Credit Agreement, and which is referred to herein as “Adjusted EBITDA per Credit Facility.” As defined in the Credit Agreement, Adjusted EBITDA per Credit Facility includes adjustments in addition to the exclusion of interest, taxes, depreciation and amortization. Accordingly, this non-GAAP financial measure is presented to allow a more comprehensive analysis of the Company’s operating performance and to provide additional information with respect to the Company’s compliance with its Credit Agreement requirements, when applicable. In addition, the Company believes that Adjusted EBITDA per Credit Facility presents relevant and useful information widely used by analysts, investors and other interested parties in the Company’s industry to evaluate, assess and benchmark the Company’s results.

EBITDA is defined as net income or loss excluding: (i) income tax expense or benefit; (ii) interest expense, net of interest income; (iii) depreciation and amortization, including film asset amortization; and (iv) amortization of deferred financing costs. Total Adjusted EBITDA is defined as EBITDA excluding: (i) share-based and other non-cash compensation expense; (ii) unrealized investment losses or gains; (iii) restructuring and other charges; and i(v) write-downs, including asset impairments and credit loss reversal. Adjusted EBITDA per Credit Facility is defined as EBITDA excluding: (i) share-based and other non-cash compensation; (ii) realized and unrealized investment gains or losses; (iii) restructuring and other charges; and (iv) write-downs, net of recoveries, including asset impairments and credit loss expense or reversal.

A reconciliation of net income (loss) attributable to common shareholders, which is the most directly comparable GAAP measure, to EBITDA and Adjusted EBITDA per Credit Facility is presented in the table below. Net income (loss) attributable to common shareholders is the most directly comparable U.S. GAAP measure because it reflects the earnings relevant to the Company’s shareholders, rather than the earnings attributable to non-controlling interests.

In this release, the Company also presents free cash flow, which is not recognized under U.S. GAAP, as a supplemental measure of the Company’s liquidity. The Company definition of free cash flow deducts only normal recurring capital expenditures, including the Company’s investment in joint revenue sharing arrangements, the purchase of property, plant and equipment and the acquisition of other intangible assets (from the Consolidated Statements of Cash Flows), from net cash provided by or used in operating activities. Management believes that free cash flow is a supplemental measure of the cash flow available to reduce debt, add to cash balances, and fund other financing activities. Free cash flow does not represent residual cash flow available for discretionary expenditures. A reconciliation of cash provided by operating activities to free cash flow is presented below.

Adjusted EBITDA per Credit Facility

 

 

Three Months Ended (Unaudited)

(In thousands of U.S. Dollars)

June 30, 2025

 

June 30, 2024

Revenues

$

91,684

 

 

$

88,961

 

Reported net income

$

12,235

 

 

$

5,073

 

Add (subtract):

 

 

 

Income tax expense

 

1,198

 

 

 

(3,997

)

Interest expense, net of interest income

 

321

 

 

 

1,229

 

Depreciation and amortization, including film asset amortization

 

15,896

 

 

 

18,838

 

Amortization of deferred financing costs(1)

 

492

 

 

 

492

 

EBITDA

$

30,142

 

 

$

21,635

 

Share-based and other non-cash compensation

 

7,492

 

 

 

6,970

 

Unrealized investment gains

 

(33

)

 

 

(32

)

Restructuring and other charges

 

786

 

 

 

 

Write-downs, including asset impairments and credit loss reversal

 

671

 

 

 

2,428

 

Total Adjusted EBITDA

$

39,058

 

 

$

31,001

 

Total Adjusted EBITDA margin

 

42.6

%

 

 

34.8

%

Less: Non-controlling interest

 

(2,372

)

 

 

(4,151

)

Adjusted EBITDA per Credit Facility - attributable to common shareholders

$

36,686

 

 

$

26,850

 

_______________

(1) The amortization of deferred financing costs is recorded within Interest Expense in the Condensed Consolidated Statement of Operations.

 

Twelve Months Ended (Unaudited)

 

(In thousands of U.S. Dollars)

June 30, 2025(1)

 

June 30, 2024(1)

Revenues

$

362,475

 

 

$

357,998

 

Reported net income

$

42,594

 

 

$

28,823

 

Add (subtract):

 

 

 

Income tax expense

 

12,317

 

 

 

5,867

 

Interest expense, net of interest income

 

2,879

 

 

 

3,037

 

Depreciation and amortization, including film asset amortization

 

62,310

 

 

 

66,826

 

Amortization of deferred financing costs(2)

 

1,969

 

 

 

1,969

 

EBITDA

$

122,069

 

 

$

106,522

 

Share-based and other non-cash compensation

 

24,222

 

 

 

23,450

 

Unrealized investment gains

 

(130

)

 

 

(455

)

Transaction-related expenses

 

 

 

 

3,413

 

Restructuring and other charges

 

4,592

 

 

 

1,593

 

Write-downs, including asset impairments and credit loss reversal

 

1,164

 

 

 

4,305

 

Total Adjusted EBITDA

$

151,917

 

 

$

138,828

 

Total Adjusted EBITDA margin

 

41.9

%

 

 

38.8

%

Less: Non-controlling interest

$

(17,404

)

 

$

(15,761

)

Adjusted EBITDA per Credit Facility - attributable to common shareholders

$

134,513

 

 

$

123,067

 

_______________

(1) The Senior Secured Net Leverage Ratio is calculated using Adjusted EBITDA per Credit Facility determined on a trailing twelve-month basis.

(2) The amortization of deferred financing costs is recorded within Interest Expense in the Condensed Consolidated Statement of Operations.

Adjusted Net Income Attributable to Common Shareholders and Adjusted Net Income Per Share

 

 

Three Months Ended June 30,

(Unaudited)

 

2025

 

2024

(In thousands of U.S. Dollars, except per share amounts)

Net Income

 

Per Diluted

Share

 

Net Income

 

Per Diluted

Share

Net income attributable to common shareholders

$

11,255

 

 

$

0.20

 

 

$

3,583

 

 

$

0.07

 

Adjustments(1):

 

 

 

 

 

 

 

Share-based compensation

 

7,128

 

 

 

0.13

 

 

 

6,647

 

 

 

0.12

 

Unrealized investment gains

 

(33

)

 

 

 

 

 

(32

)

 

 

 

Restructuring and other charges

 

786

 

 

 

0.01

 

 

 

 

 

 

 

Employee retention credits

 

(3,827

)

 

 

(0.07

)

 

 

 

 

 

 

Tax impact on items listed above

 

(702

)

 

 

(0.01

)

 

 

(452

)

 

 

(0.01

)

Adjusted net income(1)

$

14,607

 

 

$

0.26

 

 

$

9,746

 

 

$

0.18

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding (in thousands):

 

 

 

 

 

 

 

Basic

 

 

 

53,751

 

 

 

 

 

52,633

 

Diluted

 

 

 

55,161

 

 

 

 

 

53,428

 

_______________

(1) Reflects amounts attributable to common shareholders

 

Six Months Ended June 30,

(Unaudited)

 

2025

 

2024

(In thousands of U.S. Dollars, except per share amounts)

Net Income

 

Per Diluted

Share

 

Net Income

 

Per Diluted

Share

Net income attributable to common shareholders

$

13,582

 

 

$

0.25

 

 

$

6,857

 

 

$

0.13

 

Adjustments(1):

 

 

 

 

 

 

 

Share-based compensation

 

12,340

 

 

 

0.22

 

 

 

11,354

 

 

 

0.21

 

Unrealized investment gains

 

(65

)

 

 

 

 

 

(62

)

 

 

 

Transaction-related expenses

 

 

 

 

 

 

 

 

 

 

 

Restructuring and other charges

 

843

 

 

 

0.02

 

 

 

 

 

 

 

Employee retention credits

 

(3,827

)

 

 

(0.07

)

 

 

 

 

 

 

Tax impact on items listed above

 

(1,088

)

 

 

(0.02

)

 

 

(462

)

 

 

(0.01

)

Adjusted net income(1)

$

21,785

 

 

$

0.40

 

 

$

17,688

 

 

$

0.33

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding (in thousands):

 

 

 

 

 

 

 

Basic

 

 

 

53,448

 

 

 

 

 

52,568

 

Diluted

 

 

 

55,064

 

 

 

 

 

53,386

 

_______________

(1) Reflects amounts attributable to common shareholders.

Free Cash Flow

 

 

Six Months Ended

 

June 30,

(In thousands of U.S. Dollars)

2025

 

2024

Net cash provided by operating activities

$

30,181

 

 

$

24,070

 

Purchase of property, plant and equipment

 

(4,006

)

 

 

(2,690

)

Acquisition of other intangible assets

 

(3,376

)

 

 

(3,191

)

Free cash flow before growth CAPEX(1)

 

22,799

 

 

 

18,189

 

Investment in equipment for joint revenue sharing arrangements

 

(14,666

)

 

 

(9,757

)

Free cash flow

$

8,133

 

 

$

8,432

 

_______________

(1) Growth CAPEX is defined as capital expenditures associated with investments in equipment for joint revenue sharing arrangements.

 

Contacts

Investors:

IMAX Corporation, New York

Jennifer Horsley

212-821-0154

jhorsley@IMAX.com

Media:

IMAX Corporation, New York

Mark Jafar

212-821-0102

mjafar@imax.com

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.